D
Daniel Stahl
Researcher at King's College London
Publications - 304
Citations - 17658
Daniel Stahl is an academic researcher from King's College London. The author has contributed to research in topics: Randomized controlled trial & Mental health. The author has an hindex of 66, co-authored 272 publications receiving 14607 citations. Previous affiliations of Daniel Stahl include South London and Maudsley NHS Foundation Trust & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
The nature of dopamine dysfunction in schizophrenia and what this means for treatment
Oliver D. Howes,Joseph Kambeitz,Euitae Kim,Daniel Stahl,Mark Slifstein,Anissa Abi-Dargham,Shitij Kapur +6 more
TL;DR: The locus of the largest dopaminergic abnormality in schizophrenia is presynaptic, which affects dopamine synthesis capacity, baseline synaptic dopamine levels, and dopamine release, and future drug development should focus on the control of presYNaptic dopamine synthesis and release capacity.
Journal ArticleDOI
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar-Poli,Evangelos Papanastasiou,Daniel Stahl,Matteo Rocchetti,William T. Carpenter,Sukhwinder S. Shergill,Philip McGuire +6 more
TL;DR: Although some statistically significant effects on negative symptoms were evident, none reached the threshold for clinically significant improvement, and effects were not clinically meaningful as measured on Clinical Global Impression Severity Scale.
Journal ArticleDOI
A systematic review and meta-analysis of set-shifting ability in eating disorders.
TL;DR: Problems in set shifting as measured by a variety of neuropsychological tasks are present in people with eating disorders.
Journal ArticleDOI
Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users.
Marta Di Forti,Hannah M Sallis,Fabio Allegri,Antonella Trotta,Laura Ferraro,Simona A. Stilo,Arianna Marconi,Caterina La Cascia,Tiago Reis Marques,Carmine M. Pariante,Paola Dazzan,Valeria Mondelli,Alessandra Paparelli,Anna Kolliakou,Diana Prata,Fiona Gaughran,Anthony S. David,Craig Morgan,Daniel Stahl,Mizanur Khondoker,James H. MacCabe,Robin M. Murray +21 more
TL;DR: Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users, which is an average of 6 years earlier than that of non-cannabis users.